Home LiteratureArticle Details
PMID: 19676072 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.

European journal of immunology ·Vol. 39 ·No. 9 ·2009-09-00 ·Pages 2492-501

Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, Zheng XX, Strom TB, Hafler DA, Kuchroo VK

Abstract

TIM-3 is a molecule selectively expressed on a subset of murine IFN-gamma-secreting T helper 1 (Th1) cells but not Th2 cells, and regulates Th1 immunity and tolerance in vivo. At this time little is known about the role of TIM-3 on human T cells. To determine if TIM-3 similarly identifies and regulates Th1 cells in humans, we generated a panel of mAb specific for human TIM-3. We report that TIM-3 is expressed by a subset of activated CD4(+) cells, and that anti-CD3/anti-CD28 stimulation increases both the level of expression as well as the number of TIM-3(+) T cells. We also find that TIM-3 is expressed at high levels on in vitro polarized Th1 cells, and is expressed at lower levels on Th17 cells. In addition, human CD4(+) T cells secreted elevated levels of IFN-gamma, IL-17, IL-2, and IL-6, but not IL-10, IL-4, or TNF-alpha, when stimulated with anti-CD3/anti-CD28 in the presence of TIM-3-specific, putative antagonistic antibodies. This was not mediated by differences in proliferation or cell death, but rather by induction of cytokines at the transcriptional level. These results suggest that TIM-3 is a negative regulator of human T cells and regulates Th1 and Th17 cytokine secretion.

MeSH Terms
Antibodies, Monoclonal/pharmacology CD4-Positive T-Lymphocytes/drug effects,immunology,metabolism Cytokines/biosynthesis,drug effects,immunology Galectins/immunology,metabolism Hepatitis A Virus Cellular Receptor 2 Humans Immunologic Factors/pharmacology Membrane Proteins/immunology,metabolism T-Lymphocytes, Helper-Inducer/drug effects,immunology,metabolism Th1 Cells/drug effects,immunology,metabolism
Chemicals
Antibodies, Monoclonal Cytokines Galectins HAVCR2 protein, human Hepatitis A Virus Cellular Receptor 2 Immunologic Factors LGALS9 protein, human Membrane Proteins
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Hastings William D
Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Anderson David E
Kassam Nasim
Koguchi Ken
Greenfield Edward A
Kent Sally C
Zheng Xin Xiao
Strom Terry B
Hafler David A
Kuchroo Vijay K
References (29)
29 references, click to expand
  1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
    Nature. 2006 May 11;441(7090):235-8 PMID: 16648838
  2. Th1- or Th2-cell commitment during infectious disease: an oversimplification?
    Trends Immunol. 2001 Sep;22(9):481-2 PMID: 11556323
  3. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.
    Science. 2007 Nov 16;318(5853):1141-3 PMID: 18006747
  4. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.
    Nature. 2008 Jul 17;454(7202):350-2 PMID: 18469800
  5. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
    J Immunol. 1986 Apr 1;136(7):2348-57 PMID: 2419430
  6. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.
    Nat Immunol. 2005 Dec;6(12):1245-52 PMID: 16286920
  7. Th1-Th2 paradigm: insights from leprosy.
    J Invest Dermatol. 1994 Jun;102(6):828-32 PMID: 8006444
  8. Induction and effector functions of T(H)17 cells.
    Nature. 2008 Jun 19;453(7198):1051-7 PMID: 18563156
  9. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
    Nature. 2002 Jan 31;415(6871):536-41 PMID: 11823861
  10. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.
    Nat Immunol. 2003 Nov;4(11):1102-10 PMID: 14556006
  11. Dysregulated T cell expression of TIM3 in multiple sclerosis.
    J Exp Med. 2006 Jun 12;203(6):1413-8 PMID: 16754722
  12. Lack of TIM-3 immunoregulation in multiple sclerosis.
    J Immunol. 2008 Apr 1;180(7):4409-14 PMID: 18354161
  13. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
    J Immunol. 2008 Dec 1;181(11):7660-9 PMID: 19017954
  14. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells.
    Blood. 2007 Oct 1;110(7):2565-8 PMID: 17620455
  15. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells.
    J Immunol. 1999 Feb 1;162(3):1246-51 PMID: 9973376
  16. Th1-Th2: reliable paradigm or dangerous dogma?
    Immunol Today. 1997 Aug;18(8):387-92 PMID: 9267081
  17. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.
    Nat Immunol. 2008 Jun;9(6):650-7 PMID: 18454150
  18. Phenotypic and functional features of human Th17 cells.
    J Exp Med. 2007 Aug 6;204(8):1849-61 PMID: 17635957
  19. Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses.
    Nat Rev Immunol. 2005 Mar;5(3):251-60 PMID: 15738955
  20. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.
    Nat Immunol. 2008 Jun;9(6):641-9 PMID: 18454151
  21. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.
    J Exp Med. 2008 Jul 7;205(7):1543-50 PMID: 18591412
  22. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
    Int J Cancer. 1994 Aug 1;58(3):317-23 PMID: 7914181
  23. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer.
    J Immunol. 2001 Sep 1;167(5):2972-8 PMID: 11509647
  24. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
    J Immunol. 1999 Jan 1;162(1):494-502 PMID: 9886425
  25. TH1 and TH2 CD4+ cells in human allergic diseases.
    J Allergy Clin Immunol. 1997 Jul;100(1):1-6 PMID: 9257779
  26. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
    Nat Immunol. 2003 Nov;4(11):1093-101 PMID: 14556005
  27. Monoclonal antibodies to chemokine receptors.
    Methods Mol Biol. 2000;138:231-42 PMID: 10840763
  28. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.
    Science. 1991 Oct 11;254(5029):279-82 PMID: 1681588
  29. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
    J Exp Med. 2008 Nov 24;205(12):2763-79 PMID: 19001139
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
1521-4141
Published
2009-09-00
Pages
2492-501
Language
English
Region
Germany
NLM ID
1273201
PMCID
PMC2759376
Subset
IM
Grants
NINDS NIH HHS · R01 NS030843 · United States
NINDS NIH HHS · R01 NS045937 · United States
NINDS NIH HHS · R01 NS030863 · United States
NINDS NIH HHS · R01 NS030843-08 · United States
NINDS NIH HHS · NS30863 · United States
NINDS NIH HHS · NS045937 · United States
NINDS NIH HHS · R01 NS045937-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com